2022 Q4 Form 10-Q Financial Statement

#000173112222001869 Filed on November 07, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q4

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.77M $13.94M
YoY Change
Cash & Equivalents $12.77M $13.94M $1.803M
Short-Term Investments
Other Short-Term Assets $519.7K $446.7K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $13.29M $14.39M $1.892M
YoY Change 602.36%
LONG-TERM ASSETS
Property, Plant & Equipment $765.4K $631.3K $235.6K
YoY Change 224.92%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $7.520K
YoY Change
Other Assets $0.00 $0.00
YoY Change
Total Long-Term Assets $935.0K $631.3K $341.1K
YoY Change 174.14%
TOTAL ASSETS
Total Short-Term Assets $13.29M $14.39M $1.892M
Total Long-Term Assets $935.0K $631.3K $341.1K
Total Assets $14.22M $15.02M $2.233M
YoY Change 536.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $99.03K $39.48K $13.33K
YoY Change 642.73%
Accrued Expenses $92.77K $11.69K $35.13K
YoY Change 164.08%
Deferred Revenue $5.300K $4.900K
YoY Change
Short-Term Debt $169.9K $141.2K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $453.2K $197.2K $690.4K
YoY Change -34.36%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $68.53K
YoY Change
Total Long-Term Liabilities $68.53K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $453.2K $197.2K $690.4K
Total Long-Term Liabilities $68.53K $0.00
Total Liabilities $521.7K $197.2K $690.4K
YoY Change -24.43%
SHAREHOLDERS EQUITY
Retained Earnings -$4.088M -$2.667M -$457.6K
YoY Change 793.37%
Common Stock $10.45K $10.45K $7.000K
YoY Change 49.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $13.70M $14.82M $1.542M
YoY Change
Total Liabilities & Shareholders Equity $14.22M $15.02M $2.233M
YoY Change 536.95%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q4

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13940706 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1803285 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001901305
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41469
dei Entity Registrant Name
EntityRegistrantName
FORZA X1, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-3159685
dei Entity Address Address Line1
EntityAddressAddressLine1
3101 S. US-1
dei Entity Address City Or Town
EntityAddressCityOrTown
Ft. Pierce
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
34982
dei City Area Code
CityAreaCode
(772)
dei Local Phone Number
LocalPhoneNumber
429-2525
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
FRZA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
446685 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
88477 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2666789 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-457551 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
14821405 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1542449 usd
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15018644 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2232827 usd
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-19192 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-19192 usd
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-81357 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-100549 usd
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-85521 usd
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10450000 shares
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-186070 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1542449 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1891762 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
10450 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
14387391 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
7000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17477744 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1993000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
875874 usd
CY2021Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
105500 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
631253 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
235565 usd
CY2022Q3 us-gaap Assets
Assets
15018644 usd
CY2021Q4 us-gaap Assets
Assets
2232827 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
39484 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
13333 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11690 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
35128 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4900 usd
CY2022Q3 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
141165 usd
CY2021Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
641917 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
197239 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
690378 usd
CY2022Q3 us-gaap Liabilities
Liabilities
197239 usd
CY2021Q4 us-gaap Liabilities
Liabilities
690378 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10450000 shares
CY2022Q3 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
10450000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7000000 shares
CY2021Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
7000000 shares
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-514292 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1028157 usd
CY2022Q2 us-gaap Proceeds From Partnership Contribution
ProceedsFromPartnershipContribution
500000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-652283 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
14829489 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0298 pure
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
158705 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-1042663 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
14821405 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_z9nlLMrrzBHe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><i><span id="xdx_861_zdK9Ycdj5c52">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States “U.S. GAAP” requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. Included in those estimates are assumptions about useful life of fixed assets. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p>
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13940706 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1803285 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zsvrVfqtSBOi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><span id="xdx_864_zlHVcPXMm2Pg">Concentrations of Credit and Business Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The Company minimizes the concentration of credit risk associated with its cash by maintaining its cash with high quality federally insured financial institutions. However, cash balances in excess of the Federal Deposit Insurance Corporation (“FDIC”) insured limit of $<span id="xdx_90A_ecustom--FdicInsuredLimit_iI_c20220930_zZL8VFykEoA6" title="FDIC insured limit">250,000</span> are at risk. As of September 30, 2022 and December 31, 2021, the Company had $<span id="xdx_905_eus-gaap--CashFDICInsuredAmount_c20220930_pp0p0" title="FDIC excess amount">13,632,579</span> and $<span id="xdx_90F_eus-gaap--CashFDICInsuredAmount_c20211231_pp0p0" title="FDIC excess amount">1,492,019</span>, respectively, in excess of FDIC insured limits.</p>
CY2022Q3 FRZA Fdic Insured Limit
FdicInsuredLimit
250000 usd
CY2022Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
13632579 usd
CY2021Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
1492019 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
657616 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
238773 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
26363 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3208 usd
CY2022Q3 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
631253 usd
CY2021Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
235565 usd
CY2022Q3 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
141165 usd
CY2021Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
641917 usd
us-gaap Payments For Rent
PaymentsForRent
3400 usd
CY2022Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
8986 usd
CY2021Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
16090 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2704 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
19038 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11690 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
35128 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13940706 usd
CY2022Q3 FRZA Working Capital
WorkingCapital
14190152 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1803285 usd
CY2021Q4 FRZA Working Capital
WorkingCapital
1201384 usd
us-gaap Short Term Lease Payments
ShortTermLeasePayments
2200 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
2200 usd
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
172500 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
6.25
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Expiration Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
2027-08-16
FRZA Warrant Activity
WarrantActivity
0 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.15 pure
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
816500 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.00
FRZA Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2
P10Y
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
816500 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.00
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P9Y10M13D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
47194 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.00
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P9Y10M13D
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
769306 shares

Files In Submission

Name View Source Status
frza-20220930_cal.xml Edgar Link unprocessable
0001731122-22-001869-index-headers.html Edgar Link pending
0001731122-22-001869-index.html Edgar Link pending
0001731122-22-001869.txt Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
0001731122-22-001869-xbrl.zip Edgar Link pending
e4195_10-q.htm Edgar Link pending
e4195_ex31-1.htm Edgar Link pending
e4195_ex31-2.htm Edgar Link pending
e4195_ex32-1.htm Edgar Link pending
e4195_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
frza-20220930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
frza-20220930_def.xml Edgar Link unprocessable
e4195_10-q_htm.xml Edgar Link completed
frza-20220930_pre.xml Edgar Link unprocessable
frza-20220930_lab.xml Edgar Link unprocessable